Amebicide Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025
- Transparency Market Research
Amebicide is a type of anti-infective drug. Amebicides are agents that kill or destroy amebae. Every amebicide has a different mode of action. Amebicides are used for the eradication of parasitic species of amebae in humans or animals. Amebicides are used for the treatment of various infectious diseases such as amebiasis. Amebiasis is an infection that is caused by Entamoeba histolytica. Entamoeba histolytica infects the intestinal tract of humans or animals. Amebicide drugs are given orally or intravenously. The absorption of an amebicide drug is complete and rapid. Due to rapid absorption through the gastrointestinal tract, these drugs are less effective against parasites in the lumen. Amebicide drugs are distributed to all tissues and body fluids such as the milk, the saliva, and the cerebrospinal fluid. An amebicide drug is metabolized by oxidation in the liver by mixed function oxidase, followed by glucouronylation. The drug is excreted in the urine as an unchanged drug and metabolite. Amebicide drugs can cause certain adverse effects such as oral thrush, diarrhea, metallic taste, dry mouth, vomiting, or nausea.
Increasing prevalence of parasitic infections all over the world drives the global amebicide drugs market. The increasing pool of patients suffering from amebic infections and high cost of new drugs are likely to boost this market remarkably in the next few years. The rising level of awareness, better treatment facilities, continued launch of effective drugs, and presence of favorable reimbursement policies for high-cost treatments are expected to drive the global amebicide drugs market during the forecast period. The geriatric population is more prone to infections due to their low immunity levels. Infections, especially parasitic, are becoming increasingly common among the elderly people.
The global amebicide drugs market can be categorized based on product, infection type, site of action, mechanism of action, distribution channel, and region. Based on product, the market can be classified into branded drugs and generic drugs. In terms of infection type, the amebicide drugs market can be categorized into bone infection, skin infection, ENT infections, gastrointestinal infection, surgical site infections, bloodstream infections, ventilator-associated pneumonia, and urinary tract infections. Based on site of action, the market can be segmented into luminal amebicides, systemic amebicides, and mixed (luminal and systemic) amebicides. Based on mechanism of action, the amebicide drugs market can be categorized into inactivation of enzymes, inhibition of protein synthesis, and inhibition of DNA replication. In terms of distribution channel, the market can be divided into online pharmacies, retail pharmacies, and hospital pharmacies.
Geographically, the amebicide drugs market can be divided into Latin America, Asia Pacific, Europe, North America, and Middle East & Africa. North America held the largest market share in 2016, due to presence of a large number of multi-drug-resistant ameba and high prevalence of various infections among people in the region. This region also has large geriatric population, which is more prone to different infections led by lowered level of immunity. Hence, the elderly people require use of various amebicide drugs. This, in turn, promotes growth of the amebicide drugs market in North America. Europe held the second-largest market share in 2016, due to technological advancements and increase in research and development activities in the region. The amebicide drugs market in Asia Pacific is likely to expand rapidly during the forecast period. Growth of the market in the region is attributable to developing infrastructure, growing awareness, and increasing purchasing power of people in the region. The market in Middle East & Africa and Latin America is anticipated to expand during the forecast period, due to increasing prevalence of parasitic infections in these regions.
Key players operating in the global amebicide drugs market include Romark, L.C., Sanofi, Presutti Laboratories, LLC, and Heritage Pharmaceuticals.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Pharmaceutical
PharmaceuticalChinese Markets for Mental Illness Drugs
PharmaceuticalChinese Markets for Anti-Dermatomycosis Skin Drugs
PharmaceuticalChinese Markets for Incretion Drugs
PharmaceuticalChinese Markets for Hypertension Drugs
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017